Klinické štúdie Glióm v štáte Pennsylvania
19 štúdií pre Glióm hľadá účastníkov v zariadeniach v štáte Pennsylvania.
Mestá v štáte Pennsylvania
Oficiálny text štúdie (anglicky)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Geisinger Medical Center, Danville
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- a 1 ďalších
Prebieha náborFáza 1/2
12 Months – 21 Years · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Prebieha náborFáza 1/2
Do veku 25 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT04094610Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
- The Children s Hospital of Philadelphia, Philadelphia
Prebieha náborSkorá fáza 1
Vek 1 až 21 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT05555550ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Children's Hospital of Philidelphia, Philidelphia
Prebieha náborFáza 2
12 Months – 39 Years · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06838676Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborObservačná štúdia
12 Months – 39 Years · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 2
Vek 12 až 39 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Thomas Jefferson University Hospital, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 2
Vek 3 až 39 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 1
Vek 1 až 25 · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT04485559A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Thomas Jefferson University, Philadelphia
Prebieha náborFáza 2
Vek 8 a viac · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Lehigh Valley Health Network (Data Collection Only), Allentown
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT05188508Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 1/2
Vek 4 až 39 · Všetky pohlavia · Aktualizované 20. 7. 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborSkorá fáza 1Vítaní zdravých dobrovoľníkov
Vek 1 až 21 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 2
12 Months – 39 Years · Všetky pohlavia · Aktualizované 29. 5. 2026 · NCT05843253A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 4. 2026 · NCT06326411A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborSkorá fáza 1
Do veku 21 · Všetky pohlavia · Aktualizované 18. 3. 2026 · NCT04655404All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
- University of Pennsylvania, Philadelphia
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT0534500218F-Fluciclovine PET-MRI in High-grade Glioma
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborSkorá fáza 1
Vek 1 až 21 · Všetky pohlavia · Aktualizované 4. 12. 2025 · NCT05553041Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.